Market revenue in 2023 | USD 1,977.2 million |
Market revenue in 2030 | USD 2,893.2 million |
Growth rate | 5.6% (CAGR from 2023 to 2030) |
Largest segment | Tablets |
Fastest growing segment | Capsules |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tablets, Capsules, Powders, Granules |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Boehringer Ingelheim, Jubilant Pharmova, Novacyt SA, Thermo Fisher Scientific Inc, Recipharm, CordenPharma, Siegfried Holding AG, Piramal Pharma Solutions, AbbVie Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage contract manufacturing market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 33.57% in 2023. Horizon Databook has segmented the Brazil oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.
The robust growth & development in biologics and the rising pharmaceutical market are expected to boost oral solid dosage contract manufacturing. Moreover, the demand for oral solid dosage contract manufacturing in the country is growing, as consumers are increasingly seeking oral solid dosage products due to the growing burden of diseases.
In addition, the country’s demand for oral solid dosage contract manufacturing can be attributed to the fact that investors continue to invest in the growth of pharmaceutical manufacturing facilities in Brazil coupled with untapped opportunities present in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil oral solid dosage contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Brazil oral solid dosage contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account